283 related articles for article (PubMed ID: 15003330)
1. CYP1A2 is not required for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced immunosuppression.
Smialowicz RJ; Burgin DE; Williams WC; Diliberto JJ; Setzer RW; Birnbaum LS
Toxicology; 2004 Apr; 197(1):15-22. PubMed ID: 15003330
[TBL] [Abstract][Full Text] [Related]
2. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
[TBL] [Abstract][Full Text] [Related]
3. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
Hakk H; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
[TBL] [Abstract][Full Text] [Related]
4. Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Smith AG; Clothier B; Carthew P; Childs NL; Sinclair PR; Nebert DW; Dalton TP
Toxicol Appl Pharmacol; 2001 Jun; 173(2):89-98. PubMed ID: 11384210
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of the SRBC PFC assay versus ELISA for detection of immunosuppression by TCDD and TCDD-like congeners.
Johnson CW; Williams WC; Copeland CB; DeVito MJ; Smialowicz RJ
Toxicology; 2000 Dec; 156(1):1-11. PubMed ID: 11162871
[TBL] [Abstract][Full Text] [Related]
6. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
[TBL] [Abstract][Full Text] [Related]
7. Suppressive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the high-affinity antibody response in C57BL/6 mice.
Inouye K; Ito T; Fujimaki H; Takahashi Y; Takemori T; Pan X; Tohyama C; Nohara K
Toxicol Sci; 2003 Aug; 74(2):315-24. PubMed ID: 12773764
[TBL] [Abstract][Full Text] [Related]
8. Opposite effects of 2,2',4,4',5,5'-hexachlorobiphenyl and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antibody response to sheep erythrocytes in mice.
Smialowicz RJ; DeVito MJ; Riddle MM; Williams WC; Birnbaum LS
Fundam Appl Toxicol; 1997 Jun; 37(2):141-9. PubMed ID: 9242587
[TBL] [Abstract][Full Text] [Related]
9. Immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a complex environmental mixture from the Love Canal.
Silkworth JB; Cutler DS; Sack G
Fundam Appl Toxicol; 1989 Feb; 12(2):303-12. PubMed ID: 2714530
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
11. Influence of the Ah locus on the humoral immunotoxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: evidence for Ah-receptor-dependent and Ah-receptor-independent mechanisms of immunosuppression.
Kerkvliet NI; Steppan LB; Brauner JA; Deyo JA; Henderson MC; Tomar RS; Buhler DR
Toxicol Appl Pharmacol; 1990 Aug; 105(1):26-36. PubMed ID: 2168100
[TBL] [Abstract][Full Text] [Related]
12. Altered thyroxin and retinoid metabolic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin in aryl hydrocarbon receptor-null mice.
Nishimura N; Yonemoto J; Miyabara Y; Fujii-Kuriyama Y; Tohyama C
Arch Toxicol; 2005 May; 79(5):260-7. PubMed ID: 15902423
[TBL] [Abstract][Full Text] [Related]
13. Effects of CYP1A2 on disposition of 2,3,7, 8-tetrachlorodibenzo-p-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 2,2',4,4',5,5'-hexachlorobiphenyl in CYP1A2 knockout and parental (C57BL/6N and 129/Sv) strains of mice.
Diliberto JJ; Burgin DE; Birnbaum LS
Toxicol Appl Pharmacol; 1999 Aug; 159(1):52-64. PubMed ID: 10448125
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
15. Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Takemoto K; Nakajima M; Fujiki Y; Katoh M; Gonzalez FJ; Yokoi T
Arch Toxicol; 2004 Jun; 78(6):309-15. PubMed ID: 15004665
[TBL] [Abstract][Full Text] [Related]
16. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
17. Functional cytochrome P450 1A enzymes are induced in mouse and human islets following pollutant exposure.
Ibrahim M; MacFarlane EM; Matteo G; Hoyeck MP; Rick KRC; Farokhi S; Copley CM; O'Dwyer S; Bruin JE
Diabetologia; 2020 Jan; 63(1):162-178. PubMed ID: 31776611
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on humoral immunity and lymphocyte subpopulations: differences between mice and rats.
Smialowicz RJ; Riddle MM; Williams WC; Diliberto JJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):248-56. PubMed ID: 8122270
[TBL] [Abstract][Full Text] [Related]
19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated oxidative stress in CYP1A2 knockout (CYP1A2-/-) mice.
Slezak BP; Diliberto JJ; Birnbaum LS
Biochem Biophys Res Commun; 1999 Oct; 264(2):376-9. PubMed ID: 10529372
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the role played by antigen challenge in the suppression of in vivo humoral immunity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Matulka RA; Morris DL; Wood SW; Kaminski NE; Holsapple MP
Arch Toxicol; 1997; 72(1):45-51. PubMed ID: 9458190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
